CoreCap Advisors
VRTX icon

CoreCap Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

CoreCap Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$323K Buy
618
+176
+40% +$90.1K 0.01% 689
2026
Q2 		$220K Sell
442
-72
-14% -$31.9K 0.01% 835
2026
Q1 		$230K Sell
514
-6
-1% -$2.8K 0.01% 761
2025
Q4 		$236K Buy
520
+30
+6% +$12.9K 0.01% 739
2025
Q3 		$192K Sell
490
-952
-66% -$398K 0.01% 812
2025
Q2 		$642K Buy
1,442
+641
+80% +$295K 0.03% 455
2025
Q1 		$388K Sell
801
-425
-35% -$198K 0.02% 519
2024
Q4 		$494K Sell
1,226
-6,622
-84% -$3.07M 0.02% 486
2024
Q3 		$3.65M Buy
7,848
+7,154
+1,031% +$3.44M 0.17% 117
2024
Q2 		$325K Sell
694
-1,194
-63% -$518K 0.03% 292
2024
Q1 		$789K Buy
1,888
+395
+26% +$167K 0.04% 329
2023
Q4 		$607K Buy
1,493
+793
+113% +$293K 0.04% 319
2023
Q3 		$243K Buy
+700
New +$245K 0.02% 460
2022
Q4 		$378K Sell
1,309
-4,719
-78% -$1.44M 0.03% 407
2022
Q3 		$1.74M Buy
6,028
+254
+4% +$73.1K 0.15% 126
2022
Q2 		$1.63M Buy
+5,774
New +$1.55M 0.13% 129
2022
Q1 		– Sell
-372
Closed -$82K – 2070
2021
Q4 		$82K Buy
+372
New +$72.3K 0.01% 832

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

CoreCap Advisors's VRTX Position: Q3 2026 in Review

CoreCap Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 40% in Q3 2026, buying an estimated $90.1K and bringing the position to 618 shares worth $323K. The position accounts for 0.01% of the portfolio, ranked #689.

CoreCap Advisors first reported a position in VRTX in Q4 2021 and has held it in 17 quarters since. The position peaked at $3.65M in Q3 2024. 440 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • CoreCap Advisors held 618 shares of Vertex Pharmaceuticals worth $323K as of Q3 2026.
  • CoreCap Advisors bought 176 Vertex Pharmaceuticals shares in Q3 2026, an estimated $90.1K.
  • Vertex Pharmaceuticals made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #689 holding.
  • CoreCap Advisors first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • CoreCap Advisors's Vertex Pharmaceuticals position peaked at $3.65M in Q3 2024.
  • 440 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.